{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:39:13Z","timestamp":1792665553716,"version":"4.5.0"},"reference-count":24,"publisher":"Walter de Gruyter GmbH","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>QT interval prolongation is a common electrocardiographic abnormality in hospitalized patients, associated with malignant ventricular arrhythmias and sudden cardiac death. Its determinants in internal medicine, and the reliability of correction formulas used to identify it, remain insufficiently characterized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective, single-center study including 277 patients hospitalized with QTc prolongation \u2014 defined by Bazett correction (QTcB &gt;450 ms in men; \u2265460 ms in women) \u2014 between January 2016 and December 2023. QTc was independently calculated using Bazett (QTcB) and Framingham (QTcF) formulas, and agreement between the two was assessed using Bland-Altman analysis. Multivariable logistic regression (complete-case analysis) explored predictors of QTcF-confirmed prolongation, and reversibility was assessed by repeat ECG performed after correction of the underlying reversible cause, or within 72 hours when no such cause was identified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Mean age was 59.2 \u00b117.2 years, with a slight female predominance (54.2%). Only 78 patients (28.1%) had QTcF-confirmed prolongation despite all meeting QTcB inclusion criteria. Bland-Altman analysis showed a mean bias of +31.7 ms between QTcB and QTcF (SD 18.9; 95% limits of agreement: \u22125.3 to +68.7 ms), strongly correlated with heart rate (r=0.92, p&lt;0.001): the overcorrection increased from +3.6 ms at heart rate &lt;70 bpm to +64.4 ms at &gt;110 bpm. QTcB normalized on the follow-up ECG in 68.2% of patients. In a complete-case multivariable model (n=96 with available serum bicarbonate), no variable reached conventional statistical significance; serum bicarbonate (OR=1.121 per mmol\/L; 95% CI: 0.991\u20131.268; p=0.069) and hypertension (OR=2.522; 95% CI: 0.875\u20137.275; p=0.087) showed borderline associations with QTcF-confirmed prolongation. In an exploratory analysis of the diabetic subgroup (n=148), peripheral neuropathy (DN4 \u22654) was associated with a 15.8 ms higher mean QTcB (age-adjusted 95% CI: 4.7\u201327.0 ms; p=0.006).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Bazett's formula substantially and heart-rate-dependently overestimates QT prolongation compared with the Framingham formula, a discrepancy now precisely quantified. QT prolongation in hospitalized internal medicine patients is predominantly acquired and reversible. Diabetic peripheral neuropathy was associated with higher QTcB values in an exploratory analysis. Serum bicarbonate showed only a non-significant trend toward association with QTcF-confirmed prolongation after complete-case multivariable adjustment; this hypothesis warrants confirmation in prospective studies with complete acid-base characterization before any clinical application.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2478\/rjim-2026-0023","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:57:14Z","timestamp":1792663034000},"source":"Crossref","is-referenced-by-count":0,"title":["Prolonged QT Interval in Hospitalized Internal Medicine Patients: A Retrospective Cohort Study of Determinants and Reversibility"],"prefix":"10.2478","author":[{"given":"Donia","family":"Chebbi","sequence":"first","affiliation":[{"name":"Department of Internal Medicine , University Hospital of Ben Arous , Ben Arous , Faculty of Medicine of Tunis , Tunis El Manar University, Tunis , Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiem","family":"Bougarn","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine , University Hospital of Ben Arous , Ben Arous , Faculty of Medicine of Tunis , Tunis El Manar University, Tunis , Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8925-2320","authenticated-orcid":false,"given":"Fedy","family":"Mtar","sequence":"additional","affiliation":[{"name":"Past: Department of Internal Medicine , University Hospital of Ben Arous, Ben Arous , Faculty of Medicine of Tunis , Tunis El Manar University, Tunis, Tunisia ; Current: Department of Internal Medicine , United Health Services, Wilson Medical Center , Johnson City , NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma Ben","family":"Dahmen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine , University Hospital of Ben Arous , Ben Arous , Faculty of Medicine of Tunis , Tunis El Manar University, Tunis , Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meya","family":"Abdallah","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine , University Hospital of Ben Arous , Ben Arous , Faculty of Medicine of Tunis , Tunis El Manar University, Tunis , Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"2026102209570545071_j_rjim-2026-0023_ref_001","doi-asserted-by":"crossref","unstructured":"SEMSARIAN C., INGLES J., WILDE A.M. Sudden cardiac death in the young: the molecular autopsy and a practical approach to surviving relatives. Eur Heart J. 2015;36(21):1290\u20131296.","DOI":"10.1093\/eurheartj\/ehv063"},{"key":"2026102209570545071_j_rjim-2026-0023_ref_002","doi-asserted-by":"crossref","unstructured":"KAHLON S.S., SIKANDAR R., TEJOVATH S., et al. Diagnosing torsades de pointes based on correlation to QT interval: a systematic review. Cureus. 2022;14(8):e28114.","DOI":"10.7759\/cureus.27833"},{"key":"2026102209570545071_j_rjim-2026-0023_ref_003","doi-asserted-by":"crossref","unstructured":"SCHWARTZ P.J., MOSS A.J., VINCENT G.M., CRAMPTON R.S. Diagnostic criteria for the long QT syndrome: an update. Circulation. 1993;88(2):782\u2013784.","DOI":"10.1161\/01.CIR.88.2.782"},{"key":"2026102209570545071_j_rjim-2026-0023_ref_004","doi-asserted-by":"crossref","unstructured":"VANDAEL E., VANDENBERK B., VANDENBERGHE J., WILLEMS R., FOULON V. Risk factors for QTc-prolongation: systematic review of the evidence. Int J Clin Pharm. 2017;39(1):16\u201325.","DOI":"10.1007\/s11096-016-0414-2"},{"key":"2026102209570545071_j_rjim-2026-0023_ref_005","doi-asserted-by":"crossref","unstructured":"BAZETT H.C. An analysis of the time-relations of electrocardiograms. Ann Noninvasive Electrocardiol. 1997;2(2):177\u2013194.","DOI":"10.1111\/j.1542-474X.1997.tb00325.x"},{"key":"2026102209570545071_j_rjim-2026-0023_ref_006","doi-asserted-by":"crossref","unstructured":"SAGIE A., LARSON M.G., GOLDBERG R.J., BENGTSON J.R., LEVY D. An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study). Am J Cardiol. 1992;70(7):797\u2013801.","DOI":"10.1016\/0002-9149(92)90562-D"},{"key":"2026102209570545071_j_rjim-2026-0023_ref_007","doi-asserted-by":"crossref","unstructured":"PASQUIER M., PANTET O., HUGLI O., et al. Prevalence and determinants of QT interval prolongation in medical inpatients. Intern Med J. 2012;42(8):933\u2013940.","DOI":"10.1111\/j.1445-5994.2011.02447.x"},{"key":"2026102209570545071_j_rjim-2026-0023_ref_008","doi-asserted-by":"crossref","unstructured":"ROSSI M., MARZI F., NATALE M., et al. Drug-associated QTc prolongation in geriatric hospitalized patients: a cross-sectional study in internal medicine. Drugs Real World Outcomes. 2021;8(3):325\u2013335.","DOI":"10.1007\/s40801-021-00234-x"},{"key":"2026102209570545071_j_rjim-2026-0023_ref_009","doi-asserted-by":"crossref","unstructured":"RAUTAHARJU P.M., SURAWICZ B., GETTES L.S., et al. AHA\/ACCF\/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV. J Am Coll Cardiol. 2009;53(11):982\u2013991.","DOI":"10.1016\/j.jacc.2008.12.014"},{"key":"2026102209570545071_j_rjim-2026-0023_ref_010","unstructured":"CredibleMeds. QTDrugs lists [Internet]. 2013 [cited 2024 Nov 20]. Available from: https:\/\/www.crediblemeds.org\/"},{"key":"2026102209570545071_j_rjim-2026-0023_ref_011","doi-asserted-by":"crossref","unstructured":"VANDENBERK B., VANDAEL E., ROBYNS T., et al. Which QT correction formulae to use for QT monitoring? J Am Heart Assoc. 2016;5(6):e003264.","DOI":"10.1161\/JAHA.116.003264"},{"key":"2026102209570545071_j_rjim-2026-0023_ref_012","unstructured":"RABKIN S.W., CHENG X.J., THOMPSON D.S. Detailed analysis of the impact of age on the QT interval. J Geriatr Cardiol. 2016;13(9):740\u2013748."},{"key":"2026102209570545071_j_rjim-2026-0023_ref_013","doi-asserted-by":"crossref","unstructured":"PFEIFER M.A., WEINBERG C.R., COOK D., BEST J.D., REENAN A., HALTER J.B. Differential changes of autonomic nervous system function with age in man. Am J Med. 1983;75(2):249\u2013258.","DOI":"10.1016\/0002-9343(83)91201-9"},{"key":"2026102209570545071_j_rjim-2026-0023_ref_014","doi-asserted-by":"crossref","unstructured":"COLIVICCHI F., BASSI A., SANTINI M., CALTAGIRONE C. Prognostic implications of right-sided insular damage, cardiac autonomic derangement, and arrhythmias after acute ischemic stroke. Stroke. 2005;36(8):1710\u20131715.","DOI":"10.1161\/01.STR.0000173400.19346.bd"},{"key":"2026102209570545071_j_rjim-2026-0023_ref_015","doi-asserted-by":"crossref","unstructured":"WU J., NIZHAMUDING D., LIU P., et al. QT interval prolongation in patients with acute ischemic stroke. J Int Med Res. 2019;47(12):5986\u20135995.","DOI":"10.1177\/0300060519879852"},{"key":"2026102209570545071_j_rjim-2026-0023_ref_016","doi-asserted-by":"crossref","unstructured":"NISHIYAMA T., KONDO Y., TSUBOI H., et al. QTc interval prolongation in patients with systemic lupus erythematosus treated with hydroxychloroquine. Mod Rheumatol. 2021;31(6):1107\u20131112.","DOI":"10.1080\/14397595.2021.1879368"},{"key":"2026102209570545071_j_rjim-2026-0023_ref_017","doi-asserted-by":"crossref","unstructured":"VILLA ZAPATA L., BOYCE R.D., CHOU E., et al. QTc prolongation with the use of hydroxychloroquine and concomitant arrhythmogenic medications. Drugs Real World Outcomes. 2022;9(3):415\u2013423.","DOI":"10.1007\/s40801-022-00307-5"},{"key":"2026102209570545071_j_rjim-2026-0023_ref_018","unstructured":"HREICHE R., TURGEON J. Interactions m\u00e9dicamenteuses et risque de torsades de pointes. Pharmactuel. 2005;38(3):134\u2013139."},{"key":"2026102209570545071_j_rjim-2026-0023_ref_019","doi-asserted-by":"crossref","unstructured":"TANG J.K., RABKIN S.W. Hypocalcemia-induced QT interval prolongation. Cardiology. 2022;147(2):191\u2013195.","DOI":"10.1159\/000515985"},{"key":"2026102209570545071_j_rjim-2026-0023_ref_020","doi-asserted-by":"crossref","unstructured":"SHIMAOKA T., WANG Y., MORISHIMA M., MIYAMOTO S., ONO K. Magnesium deficiency causes transcriptional downregulation of Kir2.1 and Kv4.2 channels in cardiomyocytes resulting in QT interval prolongation. Circ J. 2020;84(8):1244\u20131253.","DOI":"10.1253\/circj.CJ-20-0310"},{"key":"2026102209570545071_j_rjim-2026-0023_ref_021","doi-asserted-by":"crossref","unstructured":"DI IORIO B., TORRACA S., PISCOPO C., et al. Dialysate bath and QTc interval in patients on chronic maintenance hemodialysis: pilot study of single dialysis effects. J Nephrol. 2012;25(5):653\u2013660.","DOI":"10.5301\/jn.5000036"},{"key":"2026102209570545071_j_rjim-2026-0023_ref_022","doi-asserted-by":"crossref","unstructured":"EMMETT M. Metabolic alkalosis: a brief pathophysiologic review. Clin J Am Soc Nephrol. 2020;15(12):1848\u20131856.","DOI":"10.2215\/CJN.16041219"},{"key":"2026102209570545071_j_rjim-2026-0023_ref_023","doi-asserted-by":"crossref","unstructured":"NINKOVIC V.M., NINKOVIC S.M., MILORADOVIC V., et al. Prevalence and risk factors for prolonged QT interval and QT dispersion in patients with type 2 diabetes. Acta Diabetol. 2016;53(5):737\u2013744.","DOI":"10.1007\/s00592-016-0864-y"},{"key":"2026102209570545071_j_rjim-2026-0023_ref_024","doi-asserted-by":"crossref","unstructured":"KOBAYASHI S., NAGAO M., ASAI A., et al. Severity and multiplicity of microvascular complications are associated with QT interval prolongation in patients with type 2 diabetes. J Diabetes Investig. 2018;9(4):946\u2013951.","DOI":"10.1111\/jdi.12772"}],"container-title":["Romanian Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/rjim-2026-0023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:57:18Z","timestamp":1792663038000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/rjim-2026-0023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":24,"alternative-id":["10.2478\/rjim-2026-0023"],"URL":"https:\/\/doi.org\/10.2478\/rjim-2026-0023","relation":{},"ISSN":["2501-062X"],"issn-type":[{"value":"2501-062X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]}}}